Investment
Features
FeesSafety
Academy
More
Pluang+

Texas Stock Exchange challenges NYSE/Nasdaq with lower fees and Texas-focused ETFs

Market News
07 Oct 2026
Seeking Alpha
View Source
Bullish
Texas Stock Exchange challenges NYSE/Nasdaq with lower fees and Texas-focused ETFs

The Texas Stock Exchange (TXSE) is positioning itself to compete with the dominant NYSE and Nasdaq by leveraging Texas's strong economy and offering lower fees to attract mid-cap companies and ETFs. Early listings include ETFs focused on Texas-based firms and companies like Dillard's, Sunoco, and USA Compression. While TXSE is not yet a major disruptor for diversified investors, it aims to increase competition, reduce costs, and potentially improve shareholder returns over time.

The Texas Stock Exchange's effort to challenge Wall Street comes as Pluang's Financials sector shows a breadth of 85 priced US stocks, with 18 rising and 62 falling as of Oct 07, 2026 18:22 WIB. Notable movers include Avalanche Treasury Corporation Class A Common Stock (AVAT) at USD 1.95 with a 1-day change of -5.80% and a typical hold time on Pluang of 11 days, Deutsche Bank AG (DB) at USD 33.44 with a 1-day change of -4.81% and a typical hold time of 79 days, and Banco Santander SA (SAN) at USD 13.46 with a 1-day change of -3.93%. Pluang order activity shows DB with 100% buy interest, AVAT with 68% sell, and SAN with 93% sell activity.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
59 minutes ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
1 hour ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
3 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App